These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Statins: the new aspirin? Veillard NR; Mach F Cell Mol Life Sci; 2002 Nov; 59(11):1771-86. PubMed ID: 12530513 [TBL] [Abstract][Full Text] [Related]
5. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction? Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430 [TBL] [Abstract][Full Text] [Related]
6. Influence of statins on MHC class I expression. Singh P; Kohr D; Kaps M; Blaes F Ann N Y Acad Sci; 2009 Sep; 1173():746-51. PubMed ID: 19758224 [TBL] [Abstract][Full Text] [Related]
7. Microcirculation as a target for the anti-inflammatory properties of statins. Scalia R; Stalker TJ Microcirculation; 2002 Dec; 9(6):431-42. PubMed ID: 12483541 [TBL] [Abstract][Full Text] [Related]
8. Beyond lipid-lowering: effects of statins on endothelial nitric oxide. Laufs U Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978 [TBL] [Abstract][Full Text] [Related]
9. Effects of statins on the vasculature: Implications for aggressive lipid management in the cardiovascular metabolic syndrome. Sowers JR Am J Cardiol; 2003 Feb; 91(4A):14B-22B. PubMed ID: 12615294 [TBL] [Abstract][Full Text] [Related]
10. Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis. Arnaud C; Veillard NR; Mach F Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):127-34. PubMed ID: 15853754 [TBL] [Abstract][Full Text] [Related]
11. Lipid and non-lipid effects of statins. Paoletti R; Bolego C; Cignarella A Handb Exp Pharmacol; 2005; (170):365-88. PubMed ID: 16596807 [TBL] [Abstract][Full Text] [Related]
12. [Pleiotrophic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors)]. Igel M; Sudhop T; von Bergmann K Arzneimittelforschung; 2003; 53(8):545-53. PubMed ID: 13677244 [TBL] [Abstract][Full Text] [Related]
13. Prevention of stroke and dementia with statins: Effects beyond lipid lowering. Vaughan CJ Am J Cardiol; 2003 Feb; 91(4A):23B-29B. PubMed ID: 12615295 [TBL] [Abstract][Full Text] [Related]
16. The pleiotropic effects of statins. Calabrò P; Yeh ET Curr Opin Cardiol; 2005 Nov; 20(6):541-6. PubMed ID: 16234628 [TBL] [Abstract][Full Text] [Related]
17. Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases? McCarey DW; Sattar N; McInnes IB Arthritis Res Ther; 2005; 7(2):55-61. PubMed ID: 15743490 [TBL] [Abstract][Full Text] [Related]
18. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering. Pedersen TR Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729 [TBL] [Abstract][Full Text] [Related]
19. [In vitro study over statins effects on cellular growth curves and its reversibility with mevalonate]. Millan Núñez-Cortés J; Alvarez Rodriguez Y; Alvarez Novés G; Recarte Garcia-Andrade C; Alvarez-Sala Walther L Clin Investig Arterioscler; 2014; 26(1):1-9. PubMed ID: 24126321 [TBL] [Abstract][Full Text] [Related]
20. Regulation of different inflammatory diseases by impacting the mevalonate pathway. Zeiser R; Maas K; Youssef S; Dürr C; Steinman L; Negrin RS Immunology; 2009 May; 127(1):18-25. PubMed ID: 19191903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]